Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/2003
03/19/2003EP1292317A1 Hypotensive and hypertensive properties of renomedullar extracts
03/19/2003EP1292249A1 Tissue engineered stents
03/19/2003EP1073443A4 Method for preparing a diafiltered stabilized blood product
03/19/2003EP0917472B1 Antiprotozoal composition
03/19/2003EP0910409A4 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
03/19/2003EP0874635B1 Nonimmunogenic platelet and red blood cell compositions
03/19/2003EP0851784B1 Blood processing systems and methods for collecting mono nuclear cells
03/19/2003EP0833644B1 Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1403569A In vivo established strain of genetic recombined inteferon and its use
03/19/2003CN1403567A Prepn process of live lactic and butyric acid bucillus product
03/19/2003CN1403148A Medicines composition for treating coronary heart disease ventricular premature beat and its prepn
03/19/2003CN1403147A Medicines composition for raising body's immunity and its prepn
03/19/2003CN1403142A Suppository for treating piles and other anorectal diseases and its prepn
03/19/2003CN1403140A Medicine for treating acute and chronic hepatitis B
03/19/2003CN1403135A Medicine for treating diabetes and its complication
03/19/2003CN1403128A Chinese medicine for treating deep ulcer and bedsore
03/19/2003CN1403127A Medicine for treating hyperthyroidism and its prepn
03/19/2003CN1403126A Haidan medicine for treating cardiac and cerebral vascular diseases and its prepn
03/19/2003CN1403121A Piles treating medicine and its prepn
03/19/2003CN1403119A Medicine for treating cerebral thrombus and its prepn
03/19/2003CN1403107A Pain-stopping bone-penetrating ointment and its prepn
03/19/2003CN1403101A Fracture-setting silky fowl ointment and its prepn
03/19/2003CN1403098A Ointment for treating piles and other anorectal diseases and its prepn
03/19/2003CN1403097A Sore ulcer treating ointment and its prepn
03/19/2003CN1403096A Bear bile powder eye drop and its prepn
03/19/2003CN1403095A Stress stimulant injection and its recipe and production process
03/19/2003CN1403094A Low-condensing agent universal freeze-dried blood plasma
03/19/2003CN1103369C Bacillus preparation and its preparing process and use
03/19/2003CN1103229C Electuary for treating allergic respiratory system diseases
03/19/2003CN1103228C Fresh deer's blood health medicated wine and its preparing method
03/19/2003CN1103225C Plaster for treating osteophytosis
03/19/2003CN1103222C External use medicinal liquid for treating psoriasis
03/19/2003CA2422817A1 Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use
03/19/2003CA2358146A1 A method of inhibiting immunologically mediated abortions
03/18/2003US6534629 Isolated protein inhibiting blood coagulation factor X; use in drugs
03/18/2003US6534538 A non-murine heart valve cell containing an exogenous nucleic acid that encodes a polypeptide having nitric oxide synthase activity; slows heart valve degeneration, thrombosis, and calcification, treats carcinoid heart disease
03/18/2003US6534310 Suppression of proteolytic activity by dysfunctional protease formation
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534095 Pulsatile acidification wave demineralization process for producing osteoinductive bone; and osteoinductive bone produced thereby
03/18/2003US6534056 Therapeutic and diagnostic uses of protein tyrosine phosphatase TC-PTP
03/18/2003US6534055 Methods for selectively stimulating proliferation of T cells
03/18/2003US6534054 Probiotic/therapeutic uses of nonpathogenic probiobiotic microorganisms; manufacturing the formulation from the plant derived material
03/18/2003US6534053 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
03/18/2003US6534052 Cardiac function comprising implantation of embryonic stem cell in which differentiation has been initiated
03/18/2003US6534051 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
03/18/2003US6534049 Synthetic soil-extract materials and medicaments for human immunodeficiency viruses based thereon
03/18/2003US6533819 Injectable implants for tissue augmentation and restoration
03/18/2003CA2210449C Method for preparing macrophages, and kits and compositions therefor
03/18/2003CA2139652C Thrombin-inhibitors
03/18/2003CA2121370C Specific tolerance in transplantation
03/14/2003CA2357403A1 A pax-encoding vector and use thereof
03/13/2003WO2003020958A2 Campylobacter typing
03/13/2003WO2003020955A2 Use of recipient endothelial cells for enhanced vascularization of tissue and tissue-engineered construct transplants
03/13/2003WO2003020920A1 Culture system for rapid expansion of human embryonic stem cells
03/13/2003WO2003020908A2 Multi-lineage directed induction of bone marrow stromal cell differentiation
03/13/2003WO2003020904A2 Methods of generating human cd4+ th1 cells
03/13/2003WO2003020889A2 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003WO2003020876A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
03/13/2003WO2003020292A1 A product for prolonging life only made from biological materials
03/13/2003WO2003020191A1 Cellulose membranes for biodegradable scaffolds
03/13/2003WO2003020172A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues
03/13/2003WO2003020116A2 Fixed-dried red blood cells
03/13/2003WO2003020113A2 The use of low-power laser irradiation for enhanced vascularization of tissue and tissue-engineered construct transplants
03/13/2003WO2003020104A2 Method of treating systemic inflammatory response syndrome
03/13/2003WO2003020039A1 Immune tolerance to predetermined antigens
03/13/2003WO2002097066A8 Human vascular progenitor cells
03/13/2003WO2002096447A3 Pharmaceutical preparation containing active ingredients extracted from the plants centella asiatica, mahonia aquifolium and viola tricolor
03/13/2003WO2002095006A3 Muscle-specific expression vectors
03/13/2003WO2002094344A3 Method and apparatus for removal of insulin binding proteins (ibp) from biological fluids
03/13/2003WO2002091997A3 Oncolytic virus therapy
03/13/2003WO2002078742A3 Methods and compositions for treatment of immune dysfunction disorders
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002074158A3 Two-phase processing of thermosensitive polymers for use as biomaterials
03/13/2003WO2002068654A3 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
03/13/2003WO2002067762A3 Muscle-polymer constructs for bone tissue engineering
03/13/2003WO2002063938A3 Production and use of dopaminergic cells to treat dopaminergic deficiencies
03/13/2003WO2002060396A3 Hair follicle neogenesis by injection of follicle progenitor cells
03/13/2003WO2002044380A3 Master bone formation transcription factor: compositions and methods of use
03/13/2003WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof
03/13/2003WO2002036829A3 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
03/13/2003WO2002030465A3 Compositions that inhibit proliferation of cancer cells
03/13/2003WO2002022151A3 Use of glp-1 and flp-2 peptides for treatment of bone disorders
03/13/2003WO2002010347A3 Directed differentiation of embryonic cells
03/13/2003WO2002000242A8 Human papilloma virus treatment
03/13/2003WO2001088103A3 Compositions and methods for tissue dedifferentiation and regeneration
03/13/2003WO2001073032A3 Compositions and methods for the therapy and diagnosis of prostate cancer
03/13/2003US20030050591 Loading system and method for using the same
03/13/2003US20030050460 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cardiovascular and bone disorders
03/13/2003US20030050273 Administering recombinant adeno-associated virus virions with a polynucleotide encoding a glial cell line-derived neutrotrophic factor polypeptide operably linked to expression control
03/13/2003US20030050272 Purified rat apoptosis-specific eucaryotic initiation Factor-5A (eIF-5A) and deoxyhypusine synthase nucleic acids and polypeptides
03/13/2003US20030050271 Infecting the vasculature of an organ or a tissue other than a liver with a vector carrying genetic material of interest for a time under conditions which protect from ischemic damage
03/13/2003US20030050234 Conotoxin peptide extracted from the venom of a marine snail, Conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics
03/13/2003US20030049843 Gene delivery vectors with cell type specificity for mesenchymal stem cells
03/13/2003US20030049838 Generation of neuronal cell for use in the treatment of nervous system disorders; prepare nutrient broth contain nerve growth factor, inoculate with cells, propagate and monitor cells
03/13/2003US20030049837 In vitro proliferation of pluripotent neural stem cell; obtain mammalian neural tissues, dissociate neural tissue into suspension, culture, passaging neural stem cell progeny to a second culture and propagate cells
03/13/2003US20030049823 eNOS mutations useful for gene therapy and therapeutic screening
03/13/2003US20030049725 Anti-TNF antibodies, compositions, methods and uses
03/13/2003US20030049601 Detecting hepatitis in sample; obtain sample, incubate with binding agent, detect complex, presence of complex indicate hepatitis virus
03/13/2003US20030049339 Nucleic acid encoding a lectin derived progenitor cell preservation factor
1 ... 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 ... 1259